Breaking News

List Bio Raises $48.4M for Global Scale-Up

Plans to build a large-scale manufacturing facility in Fishers, Indiana.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

List Biotherapeutics has unveiled plans for a new manufacturing facility in the Fishers Life Science & Innovation Park, Indiana after closing their Series A round investment. List Bio is the latest venture of Genome and Company, a global provider of microbiome anticancer drug development, which has expanded into the U.S. in the last 18 months with a majority strategic investment in List Labs and Scioto Biosciences located in Campbell, CA and Fishers, IN. The new company raised a $31 mi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters